December 09, 2025 21:42 ET | Source: Dyne Therapeutics, Inc. WALTHAM, Mass., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc.…
– New findings demonstrate a 72% HI-E response rate at Week 16 with meaningful hemoglobin improvement –– Strong activity observed…
HUNTINGTON BEACH, Calif., Dec. 4, 2025 – Expanding its acclaimed ZXi Iron family into the game improvement category like never…
“The quarter reflects broad growth across all verticals, expanding VSDHOne adoption, and strategic investments aimed at supporting margin improvement and…
AHMEDABAD, India, Nov. 13, 2025 /PRNewswire/ -- VGL Limited ("VGL" or the "Company") today reported results for the quarter (Q2…
Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…
Strong execution across all product lines led to gross margin improvement by 44% BANGALORE, India, Oct. 23, 2025 /PRNewswire/ --…
Collaboration with Schools and Communities to Protect Children and Vulnerable Road Users In the compact and dynamic city-state of most…
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…
MUMBAI, India, Aug. 27, 2025 /PRNewswire/ -- Urban Company Limited today announced the launch of Revamp, a new sub-brand, to redefine…